Resultado da Busca
21 de fev. de 2021 · Brain metastases (BM) from colorectal cancer (CRC) are rare. There is little available information regarding incidence, risk factors, prognostic factors, treatment, and overall survival (OS). In this systematic review we performed a research of the current literature and exposed an average incidence of 2.10%.
- Brain metastasis from colorectal cancer: Treatment, survival ...
To investigate the clinical characteristics, survival,...
- Colorectal cancer and brain metastases: An aggressive disease ...
Introduction: Brain metastases (BM) are rare in colorectal...
- Brain metastasis from colorectal cancer: Treatment, survival ...
22 de jan. de 2021 · In this study, we investigated the impact of different treatments for colorectal cancer patients with brain metastases. Methods: We identified stage 4 colorectal adenocarcinoma patients with brain metastasis using the National Cancer Database diagnosed between 2010 and 2015.
- Suleyman Yasin Goksu, Muhammad Shaalan Beg, Aravind Sanjeevaiah, Emrah Gumusgoz, David Hsieh, Muhamm...
- 2021
4 de fev. de 2020 · Brain metastasis (BM) from colorectal cancer is uncommon (0.6-1.36%). This study aims to investigate the patient characteristics, treatment modalities and prognostic factors in this rare population. Methods: 104 patients with brain metastasis disease from CRC were identified from over 30,000 colorectal cancer patients at the Mayo Clinic ...
- Zhaohui Jin, William Breen, Rui Jin, Paul D. Brown, Joleen Marie Hubbard
- 2020
7 de out. de 2022 · To investigate the clinical characteristics, survival, prognostic factors, and treatment of brain metastasis (BM) from colorectal cancer (CRC).
21 de fev. de 2021 · Colorectal cancer (CRC) is the third most common malignancy worldwide. Most patients with metastatic CRC develop liver or lung metastases, while a minority suffer from brain metastases. There...
